New E-News Header 
In This Issue
News
Resources
Advocacy
Education
ASBP Quick Links

 

 

This e-newsletter is sponsored by 
Contact Us

American Society of

Bariatric Physicians

2821 S. Parker Road
Ste. 625

Aurora, CO 80014

303.770.2526 | asbp.org

 

Staff

Laurie Traetow, CAE

Executive Director

laurie@asbp.org   

 

Beth Amelon
Administrative Coordinator

beth@asbp.org 

 

Carly Crosby
Administrative Coordinator

carly@asbp.org

 

Rachel Nevers

Intern, Marketing & Communications
rachel@asbp.org

 

Heidi Gordon

Director of Marketing &

Communications

heidi@asbp.org

 

Dana Mansell

CME Director &

Business Manager
dana@asbp.org

  

Stacy Schmidt, Ph.D.

Health Director
stacy@asbp.org

Obesity Medicine e-Weekly
 News
Planning to attend the ASBP symposium in October? Book your room today, as the hotel is nearing capacity
Please note that the ASBP room block at the Arizona Biltmore is nearing capacity; therefore, you are advised to book your room online (or via 800.950.0086, mentioning "ASBP"very soon to take advantage of the special conference rates, starting at $199 (plus taxes & resort fee). Please call the Society at 303.770.2526, if you experience problems booking a room before the reservation cut-off date of Sept. 16. Visit www.overcoming-obesity.org for more information about the ASBP 63rd Annual Obesity & Associated Conditions Symposium.
  
Greg Giesen on being a leader, part of the Overcoming Obesity Symposium on Oct. 9-10
Click to watch a preview video fromASBP Keynote Speaker Greg Giesen
Why Leading From Within?
If you are considering attending the ASBP Innovate: Cultivate the Leader in You course, then please click here to read an article about leadership from the course's keynote speaker, Greg Giesen, M.S., an author and founder of the Zen Leadership Institute. You may also click here to watch a short video preview of the course's Leading From Within: Three Keys to Living a Life with Purpose & Passion session on Wednesday, Oct. 9.
  
Have you reviewed your ASBP member profile lately on 
www.FindObesityTreatment.org?
Do you want to drive more traffic to your practice from the online patient-referral portal, www.FindObesityTreatment.org? If "yes," then now is the time to review and/or update your ASBP member profile! The Society is improving its marketing of this FREE tool for the public, including recently exhibiting at the Obesity Action Coalition conference for the general public and increasing visibility of it on ASBP social media sites. To review and improve your listing now--a simple way to help market your practice--please follow these easy steps:
 
  1. Click here to be redirected to the log-in page of the members-only section of the ASBP website. If you are already logged in, please click here.
  2. Click on "My Information" on the left side of the screen.
  3. Click on "Edit/View Information"
  4. Help your Society get to know you! Please update your member profile and share more about yourself and your expertise.
  5. Add your picture! You now have the ability to further enhance your public listing by adding a picture to your profile!
  6. When done, click the "Save" button.
Megaphone ASBP Board of Trustees election results
Thanks to all of the eligible members who voted in this year's election. The Society is the voice for your profession, which is why your participation in the decision of leaders is invaluable. We are pleased to announce election of the following individuals to office:
President-elect:Deborah Bade Horn, D.O., M.P.H., F.A.S.B.P.
Vice President: Wendy Scinta, M.D., M.S.
Secretary/Treasurer:Craig Primack, M.D., F.A.C.P., F.A.A.P.
Trustees: Crystal R. Broussard, M.D.; Ursula Inge Ferguson, D.O., F.A.C.O.I.; Ethan Lazarus, M.D.; and William C. McCarthy, M.D.
  
Click here to view the current ASBP Board of Trustees. The installation of officers and trustees will be held in conjunction with the 63rd Annual Obesity & Associated Conditions Symposium during the Awards & Board of Trustees Installation luncheon at 12:30 p.m. on Saturday, Oct. 12 at the Arizona Biltmore (Phoenix).
 
New education materials available for patients with joint pain & excess weight
The Osteoarthritis Action Alliance has created pamphlets to assist individuals affected by excess weight and who are experiencing joint pain (or have been diagnosed with arthritis) to take action steps to improve their pain. These pamphlets detail how excessive weight affects joint pain/arthritis, the benefits of losing weight for joint pain/arthritis, and how to make healthy lifestyle changes. Click a title below to download a PDF of that brochure:
Resources 
Obesity Updates: Click titles to view articles
Jakubowicz, D., et al. Obesity, July 2013.
The amount of calories eaten in a day can impact weight-loss effects, but the timing of when calories are consumed may also contribute to weight loss. A study was conducted at Tel Aviv University comparing a weight-loss diet with high-caloric intake during breakfast to an isocaloric diet with high-caloric intake at dinner. The study found that overweight women who ate their largest meal at breakfast were more likely to lose weight, decrease waist circumference and had greater improvements in insulin sensitivity than those who ate a large dinner.
Arafat, A.M., et al. JCEM, August 2013.
The appetite-regulating hormone glucagon may affect levels of satiety, which could be helpful in reducing food intake during weight loss or weight-loss maintenance.  Researchers from Berlin studied the glucagon-suppressive effects on ghrelin, both in obesity and in type 1 diabetes (T1D), with respect to the role of glucagon in appetite control. They found that administering the hormone glucagon led to sensations of satiety among individuals who were lean or had type 2 diabetes, but this effect was blunted in those who were affected by obesity.
  
Hughes, T.E., et al. Obesity, March 2013.
Inhibitors of methionine aminopetidase 2 (MetAP2), originally developed as anti-angiogenic agents for the treatment of cancer, have been shown to induce weight loss in animal models of obesity. Inhibition of MetAP2 has been shown to normalize weight, improve insulin sensitivity and reduce glucose levels in mice with diet-induced obesity. The mechanism of MetAP2 inhibitors is thought to be through reduced fat biosynthesis and increased fat oxidation and lipolysis. Beloranib blocks MetAP2 and was given to women affected by obesity intravenously (IV) 0.1, 0.3, or 0.9 mg/m2 twice weekly for four weeks in a double-blind, placebo controlled study. Patients were allowed to eat normally and were not counseled to change their exercise habits. In subjects completing four weeks, median weight loss with 0.9 mg/m2 beloranib was -3.8 kg versus -0.6 kg with placebo. Weight change for 0.1 and 0.3 mg/m2 beloranib was similar to placebo. Beloranib (0.9 mg/m2) was associated with a significant reduction in triglycerides and Low-density lipoprotein(LDL)-cholesterol, as well as improvement in C-reactive protein and reduced sense of hunger. Glucose and blood pressure were unchanged.
  
Advocacy 
AMA Advocacy Update now available

The September issue of the American Medical Association (AMA) Advocacy Update newsletter is now available for your download by clicking here.
 
A note about the AMA...Remember, your membership in the Society includes representation from the only obesity medicine-focused medical specialty society with a seat in the AMA House of Delegates. It is important we retain enough ASBP member physicians who are also members of the AMA, or we risk losing our seat.  If we lose our seat, we lose our ability to influence AMA policy, such as last month's victory in the fight for obesity being recognized as a disease. Click here to learn more.

Education

OO_SymposiumEarly registration prices end next week!

 

The ASBP 63rd Annual Obesity & Associated Conditions Symposium

promises to be this year's largest conference dedicated to clinical obesity treatment. Be part of it by registering to join us on Oct. 9-13 at the

Arizona Biltmore
 in Phoenix. Learn more about the symposium's speakers and topics via the downloadable preliminary program or visit www.overcoming-obesity.org. The symposium offers up to 30 hours of continuing medical education through these courses:             

Share your ideas with us for future conference speakers and topics 

Click here to submit your ideas for a speaker and/or topic for consideration as a presentation at a future live continuing medical education event. Proposals for the ASBP 2014 Spring Obesity Conference and the ASBP 64th Annual Obesity & Associated Conditions Symposium are now being accepted.

 

Reminder: ABOM application deadline is only two weeks away--we can help, if you still need CME to fulfill the requirements

 If you are planning to take the American Board of Obesity Medicine (ABOM) Certification Examination for Obesity Medicine Physicians in 2013, you are required to have 60 obesity medicine-related continuing medical education (CME) hours in order to submit your application, 30 of which must be live CME, which you can meet by attending the full Overcoming Obesity Symposium on Oct. 9-13. In order to count the latter hours, you must register for the symposium by Sept. 20 and submit your receipt with your exam application. The remaining 30 CME required hours may be fulfilled through recorded CME. The Society offers many at-home learning opportunities available on DVD or CD, which will ship to you right away. Click here to learn more. Plus, as an ASBP member, you not only get the benefit of discounted pricing on all ASBP live and recorded CME, but ABOM will accept a printout of the My CME page from the ASBP website as proof of any CME you have earned from the Society in the last few years. This will save you time from having to track down numerous letters and certificates--this one easy printout is all you need!

The American Society of Bariatric Physicians is a medical professional association for physicians, nurse practitioners and physician assistants who are focused on the treatment and management of patients affected by obesity and associated conditions and co-morbidities. The Society is the primary source for clinical education and training for the medical management of obesity.

Members of the Society are permitted and encouraged to share any of the content in this e-newsletter on their own blogs and websites, as appropriate.  

Advertising Disclaimer

Under a policy approved by the ASBP Executive Committee and Exhibitor/Advertiser Review Committee, commercial companies may apply to advertise in society publications. Approval does not imply ASBP endorsement or official recognition of particular products and/or services. This policy also applies to books and products marketed on behalf of ASBP members.